Immunological profile of amyotrophic lateral sclerosis patients and their cell-mediated immune responses to viral and CNS antigens
However, there was a significant reduction in mortality at day 90 (69.2% vs
"WHO Good Manufacturing Practices for Pharmaceutical Products: Main Principles." WHO Technical Report Series, No
dimethylamine, diethylamine, diisopropyl mine, diisopropylethylamine (DIPEA), diisobutylamine, trimethylamine, triethylamine (TEA), triisopropylamine, tributylamine, tert.butyl amine, pyridine, piperidine, 4- dimethylamino pyridine (DMAP), quinoline, imidazole, N-methylimidazole, 1,8- diazabicyclo[5.4.0]undec-7-ene (DBU), l,5-diazabicyclo[4.3.0]non-5-ene (DBN), dimethylaniline, N-methylmorpholine (NMM), l,4-diazabicyclo[2.2.2]octane (DABCO), 2,6-lutidine and the like